BU-NOT-SET

CONTACT US
Getting on track with FMD
  • Manufacturing
Eyes
Insight
The advantages of modified release oral dosage forms
  • Drug product
Eyes
Insight
Streamlining scale-up for drug substances
  • Drug substance
Filling
Insight
Oral solids endure and evolve
  • Drug product
Eyes
Insight
Patient-centric drug development comes of age
  • Drug product
Eyes
Insight
Looking beyond the deadline
  • Manufacturing
Eyes
Insight
Modified release formulations: improving efficacy and patient compliance
  • Drug product
Eyes
Insight
FMD: industry thoughts as serialisation deadline nears
  • Manufacturing
Eyes
Insight
Sustainability report 2019
  • Sustainability
Report
Report
Case study
  • Drug product
Optimising formulation to improve solubility ready for Phase III
Insight
  • Drug product
  • Industry trends
Trends emerging in capsule dosage form development
Fact sheet
  • Corporate
Licensing portfolio
Insight
  • Industry trends
Key trends in pharmaceutical outsourcing
Insight
  • Drug product
  • Industry trends
The latest trends and innovations in oral drug delivery
Insight
  • Corporate
Recipharm invests in African vaccine production
Insight
  • Drug product
  • Industry trends
The future of oral solid dose development and manufacturing
Report
  • Sustainability
Sustainability Report 2021
Insight
  • Corporate
Treating long-COVID with Erdosteine